Acute Interstitial Nephritis

For any patient with rising creatinine and suspected AIN, first identify immediately reversible AKI contributors: hypovolemia, reduced renal perfusion from heart failure or vascular disease, urinary obstruction, sepsis, nephrotoxin exposure, and intrinsic glomerular or tubular injury. NSAID-mediated afferent arteriolar constriction and ACE inhibitor-mediated loss of efferent arteriolar tone can clinically simulate tubulointerstitial nephritis, particularly in patients with impaired renal perfusion. PubMedPubMedTubulointerstitial Nephritis - StatPearls - NCBI Bookshelf - NIH

On the initial medication reconciliation, stop nonessential candidate agents rather than waiting for confirmatory testing. Drugs account for approximately 60% to 70% of AIN overall and 70% to 90% of biopsy-proven interstitial nephritis in reported series; commonly implicated classes include antimicrobials, NSAIDs, and proton-pump inhibitors. PubMed+2PubMedDrug-induced acute interstitial nephritis. - AbstractKidney InternationalAcute interstitial nephritis - Kidney InternationalPubMedMedication-Induced Interstitial Nephritis in the 21st Century. - Abstract Discontinue the suspected drug even when biopsy is planned, because prompt minimization of exposure is central to reversibility. NEJM+2NEJMAcute Renal Failure - The New England Journal of MedicinePubMedDrug-induced acute interstitial nephritis. - AbstractPubMedAllergic and Drug-Induced Interstitial Nephritis - StatPearls - NCBI

Document all prescription, over-the-counter, intermittent, and recently discontinued exposures, including PPIs, antibiotics, NSAIDs, diuretics, anticonvulsants, RAAS inhibitors, and cancer immunotherapy. PPI-associated AIN can be missed clinically: in one study, only one-quarter of PPI-mediated cases were suspected before biopsy. PubMedPubMedDrug-Induced Acute Interstitial Nephritis - PMC - NIH Do not rechallenge a patient with a drug strongly suspected to have caused AIN; recurrent AIN after omeprazole rechallenge has been reported. ScienceDirectScienceDirectRecurrent acute interstitial nephritis on rechallenge with omeprazole - ScienceDirect

Fever, rash, peripheral eosinophilia, eosinophiluria, and AKI may support a hypersensitivity phenotype, but the classic fever-eosinophilia-rash triad occurs in fewer than 10% of cases. Wolters KluwerWolters KluwerNaproxen Induced Acute Interstitial Nephritis... : Indian Journal of Nephrology NSAID-associated AIN may instead present with substantial renal dysfunction and proteinuria without rash or other systemic manifestations; arthralgia and microscopic hematuria may occur. Wolters KluwerWolters KluwerNaproxen Induced Acute Interstitial Nephritis... : Indian Journal of Nephrology

Obtain urinalysis with microscopy early, but interpret it as a screen for competing pathology rather than proof of AIN. Urine sediment and serum markers can help distinguish drug-induced AIN from acute tubular necrosis, glomerulonephritis, vasculitis, pyelonephritis, autoimmune AIN, and toxic exposure, but the diagnostic overlap is substantial. PubMedPubMedAllergic and Drug-Induced Interstitial Nephritis - StatPearls - NCBI In particular, eosinophiluria has limited diagnostic utility and should not be used to exclude AIN or justify corticosteroid treatment without a coherent clinicopathologic assessment. PubMedPubMedDrug-induced acute interstitial nephritis. - Abstract

Use rash morphology as an actionable discriminator. An allergic-type maculopapular eruption supports drug-associated tubulointerstitial nephritis, whereas palpable purpura should redirect the evaluation toward vasculitis. PubMedPubMedTubulointerstitial Nephritis - StatPearls - NCBI Bookshelf - NIH When the urinalysis suggests a glomerular process or the patient has systemic vasculitic features, prioritize evaluation for glomerulonephritis or vasculitis rather than empirically treating presumed AIN. PubMed+1PubMedAllergic and Drug-Induced Interstitial Nephritis - StatPearls - NCBIPubMedTubulointerstitial Nephritis - StatPearls - NCBI Bookshelf - NIH

Investigational tubular and inflammatory biomarkers, including urinary NGAL, KIM-1, MCP-1, alpha-1-microglobulin, and beta-2-microglobulin, remain insufficiently established for routine diagnostic or treatment selection. PubMedPubMedPrednisolone treatment in acute interstitial nephritis (PRAISE) – protocol for the randomized controlled trial Do not delay biopsy in a patient with persistent, unexplained AKI because a biomarker result is pending.

Drug-associated AIN is the leading diagnostic branch in developed settings, but do not stop after identifying a candidate medication. AIN can be allergic or drug-induced, infectious, autoimmune or systemic, idiopathic, or associated with hematologic disease. PubMed+2PubMedDrug-induced acute interstitial nephritis. - AbstractPubMedThe diagnosis of acute interstitial nephritis caused by infection versus antibiotic-induced interstitial nephritis: a narrative review. - AbstractPubMedMedication-Induced Interstitial Nephritis in the 21st Century. - Abstract When multiple plausible triggers coexist, kidney biopsy can confirm interstitial nephritis but may not independently identify the exact cause; causality must integrate exposure chronology, microbiology, systemic findings, and treatment response. PubMedPubMedThe diagnosis of acute interstitial nephritis caused by infection versus antibiotic-induced interstitial nephritis: a narrative review. - Abstract

In a patient with active infection who develops AKI during antibiotic treatment, determine whether infection control requires continuing or intensifying antimicrobial therapy before presuming antibiotic-induced AIN. Infection-associated AIN and antibiotic-induced AIN may demand divergent management, making premature glucocorticoid treatment hazardous when uncontrolled infection remains plausible. PubMedPubMedThe diagnosis of acute interstitial nephritis caused by infection versus antibiotic-induced interstitial nephritis: a narrative review. - Abstract

Consider systemic inflammatory disease when medication causality is weak or biopsy demonstrates granulomatous interstitial nephritis. Granulomatous interstitial nephritis has been associated with infections including tuberculosis, leprosy, histoplasmosis, and brucellosis; drug reactions; granulomatosis with polyangiitis; Crohn disease; and sarcoidosis. Wolters KluwerWolters KluwerGranulomatous Interstitial Nephritis and Acute... : Saudi Journal of Kidney Diseases and Transplantation Exclude infectious causes before treating presumed drug-induced granulomatous AIN with corticosteroids. PubMedPubMedDrug-Induced Acute Interstitial Nephritis - PMC - NIH

Do not require hypercalcemia, elevated ACE concentration, or thoracic imaging abnormalities to consider renal sarcoidosis. Isolated granulomatous sarcoid interstitial nephritis may present with severe renal failure despite normal serum calcium, urinary calcium excretion, ACE concentration, and no radiographic systemic sarcoidosis; biopsy may establish the diagnosis. Wolters KluwerWolters KluwerGranulomatous Interstitial Nephritis and Acute... : Saudi Journal of Kidney Diseases and Transplantation

Kidney biopsy is the definitive diagnostic test for AIN. PubMedPubMedAllergic and Drug-Induced Interstitial Nephritis - StatPearls - NCBI Pursue biopsy promptly in persistent or progressive unexplained AKI when the differential includes AIN versus acute tubular necrosis, glomerulonephritis, vasculitis, infection-related kidney disease, or ICI-associated injury, particularly if corticosteroids are being considered. Clinical diagnosis of drug-induced AIN is difficult without biopsy, and empiric corticosteroids carry risks even with short-term use. PubMedPubMedDrug-Induced Acute Interstitial Nephritis - PMC - NIH

Request assessment of interstitial inflammation, tubulitis, granulomas, interstitial fibrosis, tubular atrophy, and glomerular sclerosis. Tubulitis is associated with tubular injury, while the degree of interstitial fibrosis, tubular atrophy, and glomerular sclerosis provides prognostic information and can guide treatment intensity. Wiley+1WileyUrinary β2‐Microglobulin Is a Good Indicator of Proximal Tubule ...PubMedDrug-Induced Acute Interstitial Nephritis - PMC - NIH Severe fibrosis and tubular atrophy, along with dialysis dependence, predict poorer renal recovery. PubMedPubMedUpdate on Acute Tubulointerstitial Nephritis: Clinical Features, Immunologic Insights, and Diagnostic and Treatment Approaches

Biopsy findings can identify patients less likely to benefit from glucocorticoids. Avoiding corticosteroids is reasonable when biopsy demonstrates more than 75% interstitial fibrosis/tubular atrophy with significant glomerulosclerosis, because advanced chronic damage limits reversibility and shifts management toward renal support and prevention of further injury. PubMedPubMedDrug-Induced Acute Interstitial Nephritis - PMC - NIH

If biopsy cannot be safely performed, make the working diagnosis only after documented exclusion of competing causes and after stopping plausible offending drugs. Reassess serial kidney function rather than treating nonspecific urinary findings as confirmation. The uncertainty is clinically important because observational studies of corticosteroids have yielded conflicting results and no randomized trial has established their benefit in drug-induced AIN. PubMed+2PubMedDrug-Induced Acute Interstitial Nephritis - PMC - NIHPubMedShould Corticosteroids Be Used to Treat Biopsy-Proven Drug-Induced Acute Interstitial Nephritis?: CONPubMedPrednisolone treatment in acute interstitial nephritis (PRAISE) – protocol for the randomized controlled trial

After stopping a potential culprit and correcting reversible AKI factors, serially trend serum creatinine, electrolytes, bicarbonate, urine output, and dialysis requirement. Persistent kidney dysfunction beyond 3 weeks is associated with worse prognosis, likely reflecting increasing interstitial fibrosis and tubular injury. PubMedPubMedAllergic and Drug-Induced Interstitial Nephritis - StatPearls - NCBI Continued deterioration should trigger nephrology involvement and reconsideration of biopsy rather than prolonged observation.

Use cause and chronicity to frame prognosis. In a recent biopsy-confirmed ATIN cohort, 76% recovered kidney function by 6 months; recovery was more frequent in drug-related ATIN than other causes (81% versus 66%). Severe interstitial fibrosis/tubular atrophy and dialysis dependence were associated with poorer outcomes. PubMedPubMedUpdate on Acute Tubulointerstitial Nephritis: Clinical Features, Immunologic Insights, and Diagnostic and Treatment Approaches PPI-associated AIN has been linked with a lower likelihood of recovery at 6 months, potentially because exposure may be prolonged before recognition. PubMedPubMedAllergic and Drug-Induced Interstitial Nephritis - StatPearls - NCBI

If corticosteroids are being considered after diagnostic evaluation, distinguish evidence-supported timing signals from certainty of benefit. Retrospective studies associate earlier treatment with better renal recovery, but systematic review and expert debate identify substantial heterogeneity and no randomized evidence defining the magnitude of benefit or harms in drug-induced AIN. Oxford Academic+3Oxford Academicgfu326.pdf - Oxford AcademicPubMedDrug-induced acute interstitial nephritis. - AbstractPubMedShould Corticosteroids Be Used to Treat Biopsy-Proven Drug-Induced Acute Interstitial Nephritis?: CONPubMedPrednisolone treatment in acute interstitial nephritis (PRAISE) – protocol for the randomized controlled trial Obtain biopsy when feasible before treatment, especially if the clinical diagnosis is uncertain or pathology may show advanced irreversible disease. PubMedPubMedDrug-Induced Acute Interstitial Nephritis - PMC - NIH